array:24 [
  "pii" => "S1578219017302408"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2016.08.019"
  "estado" => "S300"
  "fechaPublicacion" => "2017-10-01"
  "aid" => "1655"
  "copyright" => "Elsevier España, S.L.U. and AEDV"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2017;108:e53-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 521
    "formatos" => array:3 [
      "EPUB" => 35
      "HTML" => 366
      "PDF" => 120
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731017301734"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2016.08.011"
      "estado" => "S300"
      "fechaPublicacion" => "2017-10-01"
      "aid" => "1655"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2017;108:e53-5"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 201
        "formatos" => array:3 [
          "EPUB" => 2
          "HTML" => 133
          "PDF" => 66
        ]
      ]
      "es" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">e-Casos cl&#237;nicos</span>"
        "titulo" => "Respuesta a omalizumab en 3 casos de urticaria solar"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "e53"
            "paginaFinal" => "e55"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Response to Omalizumab in Solar Urticaria&#58; Report of 3 Cases"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "P&#46; Rodr&#237;guez-Jim&#233;nez, P&#46; Chicharro, A&#46; P&#233;rez-Plaza, D&#46; de Argila"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Rodr&#237;guez-Jim&#233;nez"
              ]
              1 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Chicharro"
              ]
              2 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "P&#233;rez-Plaza"
              ]
              3 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "de Argila"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219017302408"
          "doi" => "10.1016/j.adengl.2016.08.019"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302408?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017301734?idApp=UINPBA000044"
      "url" => "/00017310/0000010800000008/v1_201710010019/S0001731017301734/v1_201710010019/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S157821901730241X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.07.004"
    "estado" => "S300"
    "fechaPublicacion" => "2017-10-01"
    "aid" => "1505"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2017;108:771-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 455
      "formatos" => array:3 [
        "EPUB" => 30
        "HTML" => 340
        "PDF" => 85
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Exophytic Tumor on the Left Temple"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "771"
          "paginaFinal" => "772"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Tumoraci&#243;n excrecente en sien izquierda"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 875
              "Ancho" => 1167
              "Tamanyo" => 242427
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Varas-Meis, M&#46;M&#46; Otero-Rivas, M&#46;&#193;&#46; Rodriguez-Prieto"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Varas-Meis"
            ]
            1 => array:2 [
              "nombre" => "M&#46;M&#46;"
              "apellidos" => "Otero-Rivas"
            ]
            2 => array:2 [
              "nombre" => "M&#46;&#193;&#46;"
              "apellidos" => "Rodriguez-Prieto"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S000173101630312X"
        "doi" => "10.1016/j.ad.2016.02.026"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101630312X?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730241X?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000008/v1_201710010015/S157821901730241X/v1_201710010015/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1578219017302391"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.07.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-10-01"
    "aid" => "1673"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2017;108:758-70"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 693
      "formatos" => array:3 [
        "EPUB" => 28
        "HTML" => 479
        "PDF" => 186
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Preservatives in Personal Hygiene and Cosmetic Products&#44; Topical Medications&#44; and Household Cleaners in Spain"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "758"
          "paginaFinal" => "770"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Conservantes en productos de higiene y cosm&#233;ticos&#44; medicamentos t&#243;picos y productos de limpieza dom&#233;stica en Espa&#241;a"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0025"
          "etiqueta" => "Figure 5"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr5.jpeg"
              "Alto" => 1384
              "Ancho" => 3325
              "Tamanyo" => 223849
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Percentage of brands containing the main preservatives used in the dermocosmetics sector&#46; IPBC&#44; iodopropynyl butylcarbamate&#59; MCI&#44; methylchloroisothiazolinone&#59; MI&#44; methylisothiazolinone&#59; PAPB&#44; polyaminopropyl biguanide&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Mar&#237;a Antonia Pastor-Nieto, Francisco Alc&#225;ntara-Nicol&#225;s, Virginia Melgar-Molero, Raquel P&#233;rez-Mesonero, Ar&#225;nzazu Vergara-S&#225;nchez, Adriana Mart&#237;n-Fuentes, Patricia Gonz&#225;lez-Mu&#241;oz, Esther de Eusebio-Murillo"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "Mar&#237;a Antonia"
              "apellidos" => "Pastor-Nieto"
            ]
            1 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "Alc&#225;ntara-Nicol&#225;s"
            ]
            2 => array:2 [
              "nombre" => "Virginia"
              "apellidos" => "Melgar-Molero"
            ]
            3 => array:2 [
              "nombre" => "Raquel"
              "apellidos" => "P&#233;rez-Mesonero"
            ]
            4 => array:2 [
              "nombre" => "Ar&#225;nzazu"
              "apellidos" => "Vergara-S&#225;nchez"
            ]
            5 => array:2 [
              "nombre" => "Adriana"
              "apellidos" => "Mart&#237;n-Fuentes"
            ]
            6 => array:2 [
              "nombre" => "Patricia"
              "apellidos" => "Gonz&#225;lez-Mu&#241;oz"
            ]
            7 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "de Eusebio-Murillo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731017302053"
        "doi" => "10.1016/j.ad.2017.04.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302053?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302391?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000008/v1_201710010015/S1578219017302391/v1_201710010015/en/main.assets"
  ]
  "en" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">e- Case Report</span>"
    "titulo" => "Response to Omalizumab in Solar Urticaria&#58; Report of 3 Cases"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "e53"
        "paginaFinal" => "e55"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "P&#46; Rodr&#237;guez-Jim&#233;nez, P&#46; Chicharro, A&#46; P&#233;rez-Plaza, D&#46; de Argila"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "P&#46;"
            "apellidos" => "Rodr&#237;guez-Jim&#233;nez"
            "email" => array:1 [
              0 => "pedro&#46;rodriguez&#46;jimenez90&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Chicharro"
          ]
          2 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "P&#233;rez-Plaza"
          ]
          3 => array:2 [
            "nombre" => "D&#46;"
            "apellidos" => "de Argila"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario de La Princesa&#44; Madrid&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Respuesta a omalizumab en 3 casos de urticaria solar"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Solar urticaria &#40;SU&#41; is an uncommon chronic inducible urticaria characterized by the development of wheals after exposure to sun radiation&#44; visible light&#44; or UV radiation&#46; Because the condition is rare&#44; there are no epidemiological data on incidence or prevalence rates&#44;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">1</span></a> although varying figures of between 2&#46;3&#37; and 17&#46;8&#37; have been reported within the group of photodermatoses&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">1</span></a> Lesions typically appear within minutes of exposure and the most common action spectra are visible light and UV-A&#46; Action spectrum and minimal urticaria dose &#40;MUD&#41; are important for diagnosis&#44; treatment&#44; and prognosis&#44; and can be used to rule out other photodermatoses&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Second-generation H<span class="elsevierStyleInf">1</span> antihistamines are the first-line treatment for inducible chronic SU&#44; just as they are for other forms of inducible chronic urticaria&#46; However&#44; most patients require either high doses or combinations of different antihistamines&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">2</span></a> An alternative first-line approach is tolerance induction through phototherapy&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">2</span></a> The use of omalizumab has also been described in several case reports and small case series of patients in recent years&#44; with varying results&#46; The principle underlying this treatment is based on a hypothetic role for immunoglobulin &#40;Ig&#41; E in the pathogenesis of inducible chronic urticaria&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">3</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Case Descriptions</span><p id="par0015" class="elsevierStylePara elsevierViewall">The clinical data for 3 patients with severe SU refractory to H<span class="elsevierStyleInf">1</span> antihistamines treated in our department over a period of 5 years are summarized in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Patient 1 had SU induced by visible light in which neither H<span class="elsevierStyleInf">1</span> antihistamines nor phototherapy proved effective&#46; Following treatment with omalizumab&#44; however&#44; she exhibited clear signs of clinical improvement &#40;she was able to tolerate sunlight for 10 times longer than before&#41; and improved test results after photoprovocation testing&#46; Patient 2 had SU to visible light triggered by indoor lights &#40;fluorescents and LEDs&#41; that prevented her from spending time in the sun&#46; After treatment with omalizumab&#44; she experienced an increase in tolerance of exposure to both indoor lights and sunlight&#46; She is now able to remain in the sun for up to 5<span class="elsevierStyleHsp" style=""></span>hours&#44; something that she had not been able to do for 15 years&#46; She also showed improved objective health-related quality of life scores on the Skindex-29 compared with baseline&#44; with a 23&#37; improvement noted for overall quality of life&#44; and additional improvements in the Symptoms&#44; Emotions&#44; and Functioning domains&#46; Patient 3&#44; whose case has been previously published&#44;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">4</span></a> had SU due to UV-B and UV-A and a very low MUD that limited the use of phototherapy&#46; She had responded poorly to H<span class="elsevierStyleInf">1</span> antihistamines&#46; She was treated twice with omalizumab but showed no response on either occasion&#46; In addition&#44; she developed a mild local reaction after the first injection in the form of pruritic wheals that resolved spontaneously&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Discussion</span><p id="par0025" class="elsevierStylePara elsevierViewall">In our review of the literature&#44; we identified 16 patients with SU treated with omalizumab &#40;8 case reports and 3 case series&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">3&#8211;14</span></a> Fourteen of the patients were adults and 2 were children&#46;<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">5&#44;6</span></a> The treatment doses varied between 150<span class="elsevierStyleHsp" style=""></span>mg&#47;mo<span class="elsevierStyleSup">7</span> and 800<span class="elsevierStyleHsp" style=""></span>mg&#47;mo&#46;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">8</span></a> Varying measures of clinical response were used&#44; and not all authors reported on this aspect of treatment&#46; Most authors used subjective criteria based on patient-reported manifestations or other health-related quality of life measures&#46; Others used phototesting<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">6&#8211;9</span></a> or the Urticaria Activity Score 7&#44; which is a validated tool for evaluating chronic urticaria&#46;<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">10</span></a> Of the 16 patients&#44; 12 &#40;75&#37;&#41; responded either partially or completely to treatment and 5 of these &#40;31&#46;2&#37;&#41; additionally showed negative provocation results&#46; Follow-up time varied from 1 month&#44; in a patient who showed complete response after a single dose&#44;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">7</span></a> to 1 year&#44; in a patient who received 12 monthly doses&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">On analyzing the cases reviewed&#44; we observed a certain tendency towards an association between high total baseline IgE levels&#44; albeit variable&#44; and greater response to treatment&#46; Seven of the 8 patients in this subgroup responded to treatment&#44; although it should be noted that some of the responders had normal IgE levels&#44; while some of the nonresponders &#40;like patient &#35;3 in our series&#41; had elevated levels&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">No severe adverse effects were mentioned in the cases reviewed&#44; and it is noteworthy that the treatment proved safe in the 2 pediatric cases described&#46;<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">5&#44;6</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Finally&#44; Aubin et al&#46;<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">15</span></a> recently reported on results from a phase II clinical trial investigating the use of omalizumab &#40;300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo for 2 months&#41; in 10 patients with SU studied by phototesting and photoprovocation &#40;action spectra&#58; UV-A&#44; UV-B&#44; and polychromatic solar spectrum&#41;&#46; The primary endpoint was the proportion of patients who did not develop SU lesions after photoprovocation with a UV radiation dose 10 times higher than the baseline MUD after 12 weeks of treatment&#46; Approximately 40&#37; of the patients showed an initial clinical improvement&#44; but the efficacy results based on the primary endpoint showed no significant differences&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion&#44; despite the limited data available from case reports and small case series on the characteristics and results of SU treatment with omalizumab&#44; the clinical response rate of 75&#37; based on reports in the literature to date is promising&#46; The 3 patients described in our series are a selection of patients with severe SU treated at our department and omalizumab proved effective in 2 of them&#46; Response was slower than that typically described for spontaneous chronic urticaria&#44; with improvement observed after 3 doses &#40;patient &#35;1&#41; or 5 doses &#40;patient &#35;2&#41;&#46; Both patients are satisfied with the results and wish to continue treatment&#46; Omalizumab may therefore be a potentially safe and useful treatment for patients with severe SU that is refractory to conventional treatment&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Ethical Disclosures</span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Protection of humans and animals</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors declare that no tests were carried out in humans or animals for the purpose of this study&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Confidentiality of data</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors declare that they have followed their hospital&#39;s protocol on the publication of data concerning patients&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Right to privacy and informed consent</span><p id="par0060" class="elsevierStylePara elsevierViewall">The authors declare that no private patient data appear in this article&#46;</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conflicts of Interest</span><p id="par0065" class="elsevierStylePara elsevierViewall">Dr de Argila has worked as a clinical advisor for Novartis and also participated in clinical trials sponsored by this company&#46; The other authors declare no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres908305"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec888229"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres908304"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec888228"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Case Descriptions"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Discussion"
        ]
        7 => array:3 [
          "identificador" => "sec0020"
          "titulo" => "Ethical Disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Protection of humans and animals"
            ]
            1 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Confidentiality of data"
            ]
            2 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        8 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Conflicts of Interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec888229"
          "palabras" => array:3 [
            0 => "Inducible chronic urticaria"
            1 => "Omalizumab"
            2 => "Solar urticaria"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec888228"
          "palabras" => array:3 [
            0 => "Urticaria cr&#243;nica inducible"
            1 => "Omalizumab"
            2 => "Urticaria solar"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">We report 3 cases of solar urticaria in which there was no response or limited response to first-line treatments with high-dose H<span class="elsevierStyleInf">1</span> antihistamines or phototherapy&#46; The patients were then treated with omalizumab&#46; Symptoms improved in 2 patients&#44; whose tolerance to sunlight increased considerably&#59; quality of life clearly improved for 1 of these patients&#46; The third experienced no improvement and developed a mild local reaction to the injected medication&#46; We conclude that omalizumab may offer a potentially safe&#44; useful alternative for patients with solar urticaria who do not respond to conventional therapy&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se presentan 3 pacientes con urticaria solar que o no hab&#237;an respondido adecuadamente o presentaban limitaciones a los tratamientos de primera l&#237;nea &#40;antihistam&#237;nicos H1 a dosis altas o fototerapia&#41;&#44; que fueron tratados con omalizumab&#46; Dos de ellos mejoraron cl&#237;nicamente con un aumento muy importante de la tolerancia a la luz&#44; uno de ellos con clara mejor&#237;a de la calidad de vida&#46; El otro paciente no mejor&#243; y desarroll&#243; una reacci&#243;n local leve a la medicaci&#243;n inyectada&#46; Omalizumab puede ser por tanto una alternativa terap&#233;utica potencialmente &#250;til y segura en urticarias solares graves no respondedoras al tratamiento convencional&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Rodr&#237;guez-Jim&#233;nez P&#44; Chicharro P&#44; P&#233;rez-Plaza A&#44; de Argila D&#46; Respuesta a omalizumab en 3 casos de urticaria solar&#46; Actas Dermosifiliogr&#46; 2017&#59;108&#58;e53&#8211;e55&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Abbreviations&#58; ARC&#44; allergic rhinoconjunctivitis&#59; Com&#44; comorbid conditions&#59; FL&#44; fluorescent light&#59; H<span class="elsevierStyleInf">1</span>A&#44; H<span class="elsevierStyleInf">1</span> antihistamines&#59; IgE&#44; immunoglobulin E&#59; MUD&#44; minimal urticaria dose&#59; PLE&#44; polymorphic light eruption&#59; PT&#44; previous treatment&#59; TsO&#44; time since onset&#59; Unr&#44; unremarkable&#59; VL&#44; visible light&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age&#44; y&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Com&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">TsO&#44; y&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">MUD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">IgE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Dose During Treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical Response&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">53&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ARC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H<span class="elsevierStyleInf">1</span>A PT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Wheal after 30<span class="elsevierStyleHsp" style=""></span>min with VL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">502<span class="elsevierStyleHsp" style=""></span>IU&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo 12 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complete with negative provocation test results&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PLE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H<span class="elsevierStyleInf">1</span>A&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Wheal after 30<span class="elsevierStyleHsp" style=""></span>min with FL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17&#46;2<span class="elsevierStyleHsp" style=""></span>IU&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo 6 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Partial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Unr&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H<span class="elsevierStyleInf">1</span>A&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">UV-B&#44; 10<span class="elsevierStyleHsp" style=""></span>mj&#47;cm<span class="elsevierStyleSup">2</span>&#59; UV-A&#44; &#60;<span class="elsevierStyleHsp" style=""></span>0&#46;6<span class="elsevierStyleHsp" style=""></span>mj&#47;cm<span class="elsevierStyleSup">2</span>&#59; SS&#44; &#60;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleHsp" style=""></span>mj&#47;cm<span class="elsevierStyleSup">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1382<span class="elsevierStyleHsp" style=""></span>IU&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">150<span class="elsevierStyleHsp" style=""></span>mg&#47;2<span class="elsevierStyleHsp" style=""></span>wk 1&#46;5 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No clinical or objective response&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo 4 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1527680.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Cases of Solar Urticaria Treated With Omalizumab&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:15 [
            0 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "N&#46; Botto"
                            1 => "E&#46; Warshaw"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2008.08.020"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2008"
                        "volumen" => "59"
                        "paginaInicial" => "909"
                        "paginaFinal" => "920"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19022098"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673610606745"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The definition&#44; diagnostic testing&#44; and management of chronic inducible urticarias - The EAACI&#47;GA2LEN&#47;EDF&#47;UNEV consensus recommendations 2016 update and revision"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Magerl"
                            1 => "S&#46; Altrichter"
                            2 => "E&#46; Borzova"
                            3 => "A&#46; Gim&#233;nez-Arnau"
                            4 => "C&#46; Grattan"
                            5 => "F&#46; Lawlor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/all.12884"
                      "Revista" => array:7 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2016"
                        "volumen" => "71"
                        "paginaInicial" => "780"
                        "paginaFinal" => "802"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26991006"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673610620399"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Metz"
                            1 => "S&#46; Altrichter"
                            2 => "E&#46; Ardelean"
                            3 => "B&#46; Kessler"
                            4 => "K&#46; Krause"
                            5 => "M&#46; Magerl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000320233"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int Arch Allergy Immunol"
                        "fecha" => "2011"
                        "volumen" => "154"
                        "paginaInicial" => "177"
                        "paginaFinal" => "180"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20733327"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Failure of omalizumab in ultraviolet-induced severe solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; P&#233;rez-Plaza"
                            1 => "M&#46;J&#46; Concha-Garz&#243;n"
                            2 => "G&#46; Solano-L&#243;pez"
                            3 => "D&#46; De Argila"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Immunology"
                        "fecha" => "2014"
                        "volumen" => "33"
                        "paginaInicial" => "147"
                        "paginaFinal" => "148"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment with omalizumab in a 16- year-old Caucasian girl with refractory solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Arasi"
                            1 => "G&#46; Crisafulli"
                            2 => "L&#46; Caminiti"
                            3 => "F&#46; Guarneri"
                            4 => "T&#46; Aversa"
                            5 => "F&#46; Porcaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12413"
                      "Revista" => array:7 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015"
                        "volumen" => "26"
                        "paginaInicial" => "583"
                        "paginaFinal" => "585"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26033828"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0870255115000086"
                          "estado" => "S300"
                          "issn" => "08702551"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful omalizumab treatment of severe solar urticaria in a 6-year-old child"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Levi"
                            1 => "Y&#46; Tal"
                            2 => "Z&#46; Dranitzki"
                            3 => "M&#46; Shalit"
                            4 => "D&#46;E&#46; Claes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12441"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015"
                        "volumen" => "26"
                        "paginaInicial" => "588"
                        "paginaFinal" => "590"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26172942"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of solar urticaria with anti-immunoglobulin E therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "O&#46; G&#252;zelbey"
                            1 => "E&#46; Ardelean"
                            2 => "M&#46; Magerl"
                            3 => "T&#46; Zuberbier"
                            4 => "M&#46; Maurer"
                            5 => "M&#46; Metz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2008.01879.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2008"
                        "volumen" => "63"
                        "paginaInicial" => "1563"
                        "paginaFinal" => "1565"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18925897"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Partial improvement of solar urticaria after omalizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "K&#46;H&#46; Waibel"
                            1 => "D&#46;A&#46; Reese"
                            2 => "R&#46;G&#46; Hamilton"
                            3 => "R&#46; Devillez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaci.2009.11.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2010"
                        "volumen" => "125"
                        "paginaInicial" => "490"
                        "paginaFinal" => "491"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20159260"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness of omalizumab in severe solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; De Dios-Vel&#225;zquez"
                            1 => "M&#46; G&#243;nzalez-De Arriba"
                            2 => "V&#46; Beteta-Gorriti"
                            3 => "E&#46; Mac&#237;as"
                            4 => "V&#46; Campan&#243;n-Toro"
                            5 => "I&#46; D&#225;vila"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.anai.2015.11.019"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Allergy Asthma Immunol"
                        "fecha" => "2016"
                        "volumen" => "116"
                        "paginaInicial" => "256"
                        "paginaFinal" => "264"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26774975"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Three cases of solar urticaria successfully treated with omalizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Baliu-Piqu&#233;"
                            1 => "P&#46; Aguilera-Peir&#243;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.13001"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2015"
                        "volumen" => "30"
                        "paginaInicial" => "704"
                        "paginaFinal" => "706"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25640906"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria&#58; A retrospective clinical analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46; Metz"
                            1 => "T&#46; Ohanyan"
                            2 => "M&#46;K&#46; Church"
                            3 => "M&#46; Maurer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jdermsci.2013.08.011"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Dermatol Sci"
                        "fecha" => "2014"
                        "volumen" => "73"
                        "paginaInicial" => "57"
                        "paginaFinal" => "62"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24060603"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109713062335"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Unique co-existence of cold and solar urticaria and its efficient treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46; Zimmer"
                            1 => "A&#46; Pevelling-Oberhag"
                            2 => "A&#46; Weber"
                            3 => "T&#46;T&#46; Gilfert"
                            4 => "U&#46; Rady-Pizarro"
                            5 => "P&#46; Staubach"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.14354"
                      "Revista" => array:7 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2016"
                        "volumen" => "174"
                        "paginaInicial" => "1150"
                        "paginaFinal" => "1152"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26678859"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673609605663"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Failure of omalizumab &#40;Xolair&#41; in the treatment of a case of solar urticaria caused by ultraviolet A and visible light"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "G&#46; Duchini"
                            1 => "W&#46; B&#228;umler"
                            2 => "A&#46;J&#46; Bircher"
                            3 => "K&#46; Scherer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1600-0781.2011.00624.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Photodermatol Photoimmunol Photomed"
                        "fecha" => "2011"
                        "volumen" => "27"
                        "paginaInicial" => "336"
                        "paginaFinal" => "337"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22092741"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Failure of omalizumab in the treatment of solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; M&#252;ller"
                            1 => "C&#46;M&#46; Schempp"
                            2 => "T&#46; Jakob"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.12922"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2016"
                        "volumen" => "30"
                        "paginaInicial" => "524"
                        "paginaFinal" => "525"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25546321"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Omalizumab in patients with severe and refractory solar urticaria&#58; A phase II multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Aubin"
                            1 => "M&#46; Avenel-Audran"
                            2 => "M&#46; Jeanmougin"
                            3 => "H&#46; Adamski"
                            4 => "J&#46;L&#46; Peyron"
                            5 => "M&#46;C&#46; Marguery"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2015.11.021"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2016"
                        "volumen" => "74"
                        "paginaInicial" => "574"
                        "paginaFinal" => "575"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26892659"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010800000008/v1_201710010015/S1578219017302408/v1_201710010015/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "34944"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "e- Case Report"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000008/v1_201710010015/S1578219017302408/v1_201710010015/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302408?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

e- Case Report
Response to Omalizumab in Solar Urticaria: Report of 3 Cases
Respuesta a omalizumab en 3 casos de urticaria solar
P. Rodríguez-Jiménez
Corresponding author
, P. Chicharro, A. Pérez-Plaza, D. de Argila
Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, Spain
Read
5310
Times
was read the article
1908
Total PDF
3402
Total HTML
Share statistics
 array:24 [
  "pii" => "S1578219017302408"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2016.08.019"
  "estado" => "S300"
  "fechaPublicacion" => "2017-10-01"
  "aid" => "1655"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "crp"
  "cita" => "Actas Dermosifiliogr. 2017;108:e53-5"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 521
    "formatos" => array:3 [
      "EPUB" => 35
      "HTML" => 366
      "PDF" => 120
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731017301734"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2016.08.011"
      "estado" => "S300"
      "fechaPublicacion" => "2017-10-01"
      "aid" => "1655"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "crp"
      "cita" => "Actas Dermosifiliogr. 2017;108:e53-5"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 201
        "formatos" => array:3 [
          "EPUB" => 2
          "HTML" => 133
          "PDF" => 66
        ]
      ]
      "es" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">e-Casos cl&#237;nicos</span>"
        "titulo" => "Respuesta a omalizumab en 3 casos de urticaria solar"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "e53"
            "paginaFinal" => "e55"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Response to Omalizumab in Solar Urticaria&#58; Report of 3 Cases"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "P&#46; Rodr&#237;guez-Jim&#233;nez, P&#46; Chicharro, A&#46; P&#233;rez-Plaza, D&#46; de Argila"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Rodr&#237;guez-Jim&#233;nez"
              ]
              1 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Chicharro"
              ]
              2 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "P&#233;rez-Plaza"
              ]
              3 => array:2 [
                "nombre" => "D&#46;"
                "apellidos" => "de Argila"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219017302408"
          "doi" => "10.1016/j.adengl.2016.08.019"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302408?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017301734?idApp=UINPBA000044"
      "url" => "/00017310/0000010800000008/v1_201710010019/S0001731017301734/v1_201710010019/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S157821901730241X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.07.004"
    "estado" => "S300"
    "fechaPublicacion" => "2017-10-01"
    "aid" => "1505"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "crp"
    "cita" => "Actas Dermosifiliogr. 2017;108:771-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 455
      "formatos" => array:3 [
        "EPUB" => 30
        "HTML" => 340
        "PDF" => 85
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Exophytic Tumor on the Left Temple"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "771"
          "paginaFinal" => "772"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Tumoraci&#243;n excrecente en sien izquierda"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:6 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 875
              "Ancho" => 1167
              "Tamanyo" => 242427
            ]
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Varas-Meis, M&#46;M&#46; Otero-Rivas, M&#46;&#193;&#46; Rodriguez-Prieto"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Varas-Meis"
            ]
            1 => array:2 [
              "nombre" => "M&#46;M&#46;"
              "apellidos" => "Otero-Rivas"
            ]
            2 => array:2 [
              "nombre" => "M&#46;&#193;&#46;"
              "apellidos" => "Rodriguez-Prieto"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S000173101630312X"
        "doi" => "10.1016/j.ad.2016.02.026"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101630312X?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901730241X?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000008/v1_201710010015/S157821901730241X/v1_201710010015/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1578219017302391"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.07.003"
    "estado" => "S300"
    "fechaPublicacion" => "2017-10-01"
    "aid" => "1673"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2017;108:758-70"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 693
      "formatos" => array:3 [
        "EPUB" => 28
        "HTML" => 479
        "PDF" => 186
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Preservatives in Personal Hygiene and Cosmetic Products&#44; Topical Medications&#44; and Household Cleaners in Spain"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "758"
          "paginaFinal" => "770"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Conservantes en productos de higiene y cosm&#233;ticos&#44; medicamentos t&#243;picos y productos de limpieza dom&#233;stica en Espa&#241;a"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0025"
          "etiqueta" => "Figure 5"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr5.jpeg"
              "Alto" => 1384
              "Ancho" => 3325
              "Tamanyo" => 223849
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Percentage of brands containing the main preservatives used in the dermocosmetics sector&#46; IPBC&#44; iodopropynyl butylcarbamate&#59; MCI&#44; methylchloroisothiazolinone&#59; MI&#44; methylisothiazolinone&#59; PAPB&#44; polyaminopropyl biguanide&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Mar&#237;a Antonia Pastor-Nieto, Francisco Alc&#225;ntara-Nicol&#225;s, Virginia Melgar-Molero, Raquel P&#233;rez-Mesonero, Ar&#225;nzazu Vergara-S&#225;nchez, Adriana Mart&#237;n-Fuentes, Patricia Gonz&#225;lez-Mu&#241;oz, Esther de Eusebio-Murillo"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "Mar&#237;a Antonia"
              "apellidos" => "Pastor-Nieto"
            ]
            1 => array:2 [
              "nombre" => "Francisco"
              "apellidos" => "Alc&#225;ntara-Nicol&#225;s"
            ]
            2 => array:2 [
              "nombre" => "Virginia"
              "apellidos" => "Melgar-Molero"
            ]
            3 => array:2 [
              "nombre" => "Raquel"
              "apellidos" => "P&#233;rez-Mesonero"
            ]
            4 => array:2 [
              "nombre" => "Ar&#225;nzazu"
              "apellidos" => "Vergara-S&#225;nchez"
            ]
            5 => array:2 [
              "nombre" => "Adriana"
              "apellidos" => "Mart&#237;n-Fuentes"
            ]
            6 => array:2 [
              "nombre" => "Patricia"
              "apellidos" => "Gonz&#225;lez-Mu&#241;oz"
            ]
            7 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "de Eusebio-Murillo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731017302053"
        "doi" => "10.1016/j.ad.2017.04.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302053?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302391?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000008/v1_201710010015/S1578219017302391/v1_201710010015/en/main.assets"
  ]
  "en" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">e- Case Report</span>"
    "titulo" => "Response to Omalizumab in Solar Urticaria&#58; Report of 3 Cases"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "e53"
        "paginaFinal" => "e55"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "P&#46; Rodr&#237;guez-Jim&#233;nez, P&#46; Chicharro, A&#46; P&#233;rez-Plaza, D&#46; de Argila"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "P&#46;"
            "apellidos" => "Rodr&#237;guez-Jim&#233;nez"
            "email" => array:1 [
              0 => "pedro&#46;rodriguez&#46;jimenez90&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Chicharro"
          ]
          2 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "P&#233;rez-Plaza"
          ]
          3 => array:2 [
            "nombre" => "D&#46;"
            "apellidos" => "de Argila"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario de La Princesa&#44; Madrid&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Respuesta a omalizumab en 3 casos de urticaria solar"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Solar urticaria &#40;SU&#41; is an uncommon chronic inducible urticaria characterized by the development of wheals after exposure to sun radiation&#44; visible light&#44; or UV radiation&#46; Because the condition is rare&#44; there are no epidemiological data on incidence or prevalence rates&#44;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">1</span></a> although varying figures of between 2&#46;3&#37; and 17&#46;8&#37; have been reported within the group of photodermatoses&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">1</span></a> Lesions typically appear within minutes of exposure and the most common action spectra are visible light and UV-A&#46; Action spectrum and minimal urticaria dose &#40;MUD&#41; are important for diagnosis&#44; treatment&#44; and prognosis&#44; and can be used to rule out other photodermatoses&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Second-generation H<span class="elsevierStyleInf">1</span> antihistamines are the first-line treatment for inducible chronic SU&#44; just as they are for other forms of inducible chronic urticaria&#46; However&#44; most patients require either high doses or combinations of different antihistamines&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">2</span></a> An alternative first-line approach is tolerance induction through phototherapy&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">2</span></a> The use of omalizumab has also been described in several case reports and small case series of patients in recent years&#44; with varying results&#46; The principle underlying this treatment is based on a hypothetic role for immunoglobulin &#40;Ig&#41; E in the pathogenesis of inducible chronic urticaria&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">3</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Case Descriptions</span><p id="par0015" class="elsevierStylePara elsevierViewall">The clinical data for 3 patients with severe SU refractory to H<span class="elsevierStyleInf">1</span> antihistamines treated in our department over a period of 5 years are summarized in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0020" class="elsevierStylePara elsevierViewall">Patient 1 had SU induced by visible light in which neither H<span class="elsevierStyleInf">1</span> antihistamines nor phototherapy proved effective&#46; Following treatment with omalizumab&#44; however&#44; she exhibited clear signs of clinical improvement &#40;she was able to tolerate sunlight for 10 times longer than before&#41; and improved test results after photoprovocation testing&#46; Patient 2 had SU to visible light triggered by indoor lights &#40;fluorescents and LEDs&#41; that prevented her from spending time in the sun&#46; After treatment with omalizumab&#44; she experienced an increase in tolerance of exposure to both indoor lights and sunlight&#46; She is now able to remain in the sun for up to 5<span class="elsevierStyleHsp" style=""></span>hours&#44; something that she had not been able to do for 15 years&#46; She also showed improved objective health-related quality of life scores on the Skindex-29 compared with baseline&#44; with a 23&#37; improvement noted for overall quality of life&#44; and additional improvements in the Symptoms&#44; Emotions&#44; and Functioning domains&#46; Patient 3&#44; whose case has been previously published&#44;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">4</span></a> had SU due to UV-B and UV-A and a very low MUD that limited the use of phototherapy&#46; She had responded poorly to H<span class="elsevierStyleInf">1</span> antihistamines&#46; She was treated twice with omalizumab but showed no response on either occasion&#46; In addition&#44; she developed a mild local reaction after the first injection in the form of pruritic wheals that resolved spontaneously&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Discussion</span><p id="par0025" class="elsevierStylePara elsevierViewall">In our review of the literature&#44; we identified 16 patients with SU treated with omalizumab &#40;8 case reports and 3 case series&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">3&#8211;14</span></a> Fourteen of the patients were adults and 2 were children&#46;<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">5&#44;6</span></a> The treatment doses varied between 150<span class="elsevierStyleHsp" style=""></span>mg&#47;mo<span class="elsevierStyleSup">7</span> and 800<span class="elsevierStyleHsp" style=""></span>mg&#47;mo&#46;<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">8</span></a> Varying measures of clinical response were used&#44; and not all authors reported on this aspect of treatment&#46; Most authors used subjective criteria based on patient-reported manifestations or other health-related quality of life measures&#46; Others used phototesting<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">6&#8211;9</span></a> or the Urticaria Activity Score 7&#44; which is a validated tool for evaluating chronic urticaria&#46;<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">10</span></a> Of the 16 patients&#44; 12 &#40;75&#37;&#41; responded either partially or completely to treatment and 5 of these &#40;31&#46;2&#37;&#41; additionally showed negative provocation results&#46; Follow-up time varied from 1 month&#44; in a patient who showed complete response after a single dose&#44;<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">7</span></a> to 1 year&#44; in a patient who received 12 monthly doses&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">On analyzing the cases reviewed&#44; we observed a certain tendency towards an association between high total baseline IgE levels&#44; albeit variable&#44; and greater response to treatment&#46; Seven of the 8 patients in this subgroup responded to treatment&#44; although it should be noted that some of the responders had normal IgE levels&#44; while some of the nonresponders &#40;like patient &#35;3 in our series&#41; had elevated levels&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">No severe adverse effects were mentioned in the cases reviewed&#44; and it is noteworthy that the treatment proved safe in the 2 pediatric cases described&#46;<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">5&#44;6</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">Finally&#44; Aubin et al&#46;<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">15</span></a> recently reported on results from a phase II clinical trial investigating the use of omalizumab &#40;300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo for 2 months&#41; in 10 patients with SU studied by phototesting and photoprovocation &#40;action spectra&#58; UV-A&#44; UV-B&#44; and polychromatic solar spectrum&#41;&#46; The primary endpoint was the proportion of patients who did not develop SU lesions after photoprovocation with a UV radiation dose 10 times higher than the baseline MUD after 12 weeks of treatment&#46; Approximately 40&#37; of the patients showed an initial clinical improvement&#44; but the efficacy results based on the primary endpoint showed no significant differences&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion&#44; despite the limited data available from case reports and small case series on the characteristics and results of SU treatment with omalizumab&#44; the clinical response rate of 75&#37; based on reports in the literature to date is promising&#46; The 3 patients described in our series are a selection of patients with severe SU treated at our department and omalizumab proved effective in 2 of them&#46; Response was slower than that typically described for spontaneous chronic urticaria&#44; with improvement observed after 3 doses &#40;patient &#35;1&#41; or 5 doses &#40;patient &#35;2&#41;&#46; Both patients are satisfied with the results and wish to continue treatment&#46; Omalizumab may therefore be a potentially safe and useful treatment for patients with severe SU that is refractory to conventional treatment&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Ethical Disclosures</span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Protection of humans and animals</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors declare that no tests were carried out in humans or animals for the purpose of this study&#46;</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Confidentiality of data</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors declare that they have followed their hospital&#39;s protocol on the publication of data concerning patients&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Right to privacy and informed consent</span><p id="par0060" class="elsevierStylePara elsevierViewall">The authors declare that no private patient data appear in this article&#46;</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conflicts of Interest</span><p id="par0065" class="elsevierStylePara elsevierViewall">Dr de Argila has worked as a clinical advisor for Novartis and also participated in clinical trials sponsored by this company&#46; The other authors declare no conflicts of interest&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:3 [
          "identificador" => "xres908305"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec888229"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres908304"
          "titulo" => "Resumen"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec888228"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Case Descriptions"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Discussion"
        ]
        7 => array:3 [
          "identificador" => "sec0020"
          "titulo" => "Ethical Disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Protection of humans and animals"
            ]
            1 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Confidentiality of data"
            ]
            2 => array:2 [
              "identificador" => "sec0035"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        8 => array:2 [
          "identificador" => "sec0040"
          "titulo" => "Conflicts of Interest"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec888229"
          "palabras" => array:3 [
            0 => "Inducible chronic urticaria"
            1 => "Omalizumab"
            2 => "Solar urticaria"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec888228"
          "palabras" => array:3 [
            0 => "Urticaria cr&#243;nica inducible"
            1 => "Omalizumab"
            2 => "Urticaria solar"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">We report 3 cases of solar urticaria in which there was no response or limited response to first-line treatments with high-dose H<span class="elsevierStyleInf">1</span> antihistamines or phototherapy&#46; The patients were then treated with omalizumab&#46; Symptoms improved in 2 patients&#44; whose tolerance to sunlight increased considerably&#59; quality of life clearly improved for 1 of these patients&#46; The third experienced no improvement and developed a mild local reaction to the injected medication&#46; We conclude that omalizumab may offer a potentially safe&#44; useful alternative for patients with solar urticaria who do not respond to conventional therapy&#46;</p></span>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se presentan 3 pacientes con urticaria solar que o no hab&#237;an respondido adecuadamente o presentaban limitaciones a los tratamientos de primera l&#237;nea &#40;antihistam&#237;nicos H1 a dosis altas o fototerapia&#41;&#44; que fueron tratados con omalizumab&#46; Dos de ellos mejoraron cl&#237;nicamente con un aumento muy importante de la tolerancia a la luz&#44; uno de ellos con clara mejor&#237;a de la calidad de vida&#46; El otro paciente no mejor&#243; y desarroll&#243; una reacci&#243;n local leve a la medicaci&#243;n inyectada&#46; Omalizumab puede ser por tanto una alternativa terap&#233;utica potencialmente &#250;til y segura en urticarias solares graves no respondedoras al tratamiento convencional&#46;</p></span>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Rodr&#237;guez-Jim&#233;nez P&#44; Chicharro P&#44; P&#233;rez-Plaza A&#44; de Argila D&#46; Respuesta a omalizumab en 3 casos de urticaria solar&#46; Actas Dermosifiliogr&#46; 2017&#59;108&#58;e53&#8211;e55&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Abbreviations&#58; ARC&#44; allergic rhinoconjunctivitis&#59; Com&#44; comorbid conditions&#59; FL&#44; fluorescent light&#59; H<span class="elsevierStyleInf">1</span>A&#44; H<span class="elsevierStyleInf">1</span> antihistamines&#59; IgE&#44; immunoglobulin E&#59; MUD&#44; minimal urticaria dose&#59; PLE&#44; polymorphic light eruption&#59; PT&#44; previous treatment&#59; TsO&#44; time since onset&#59; Unr&#44; unremarkable&#59; VL&#44; visible light&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age&#44; y&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Com&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">TsO&#44; y&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">MUD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">IgE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Dose During Treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical Response&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">53&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">ARC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H<span class="elsevierStyleInf">1</span>A PT&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Wheal after 30<span class="elsevierStyleHsp" style=""></span>min with VL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">502<span class="elsevierStyleHsp" style=""></span>IU&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo 12 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complete with negative provocation test results&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">65&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PLE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H<span class="elsevierStyleInf">1</span>A&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Wheal after 30<span class="elsevierStyleHsp" style=""></span>min with FL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17&#46;2<span class="elsevierStyleHsp" style=""></span>IU&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo 6 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Partial&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Unr&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">H<span class="elsevierStyleInf">1</span>A&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">UV-B&#44; 10<span class="elsevierStyleHsp" style=""></span>mj&#47;cm<span class="elsevierStyleSup">2</span>&#59; UV-A&#44; &#60;<span class="elsevierStyleHsp" style=""></span>0&#46;6<span class="elsevierStyleHsp" style=""></span>mj&#47;cm<span class="elsevierStyleSup">2</span>&#59; SS&#44; &#60;<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleHsp" style=""></span>mj&#47;cm<span class="elsevierStyleSup">2</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1382<span class="elsevierStyleHsp" style=""></span>IU&#47;mL&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">150<span class="elsevierStyleHsp" style=""></span>mg&#47;2<span class="elsevierStyleHsp" style=""></span>wk 1&#46;5 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">No clinical or objective response&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">300<span class="elsevierStyleHsp" style=""></span>mg&#47;mo 4 mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1527680.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Cases of Solar Urticaria Treated With Omalizumab&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:15 [
            0 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "N&#46; Botto"
                            1 => "E&#46; Warshaw"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2008.08.020"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2008"
                        "volumen" => "59"
                        "paginaInicial" => "909"
                        "paginaFinal" => "920"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19022098"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673610606745"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The definition&#44; diagnostic testing&#44; and management of chronic inducible urticarias - The EAACI&#47;GA2LEN&#47;EDF&#47;UNEV consensus recommendations 2016 update and revision"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Magerl"
                            1 => "S&#46; Altrichter"
                            2 => "E&#46; Borzova"
                            3 => "A&#46; Gim&#233;nez-Arnau"
                            4 => "C&#46; Grattan"
                            5 => "F&#46; Lawlor"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/all.12884"
                      "Revista" => array:7 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2016"
                        "volumen" => "71"
                        "paginaInicial" => "780"
                        "paginaFinal" => "802"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26991006"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673610620399"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Metz"
                            1 => "S&#46; Altrichter"
                            2 => "E&#46; Ardelean"
                            3 => "B&#46; Kessler"
                            4 => "K&#46; Krause"
                            5 => "M&#46; Magerl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000320233"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int Arch Allergy Immunol"
                        "fecha" => "2011"
                        "volumen" => "154"
                        "paginaInicial" => "177"
                        "paginaFinal" => "180"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20733327"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Failure of omalizumab in ultraviolet-induced severe solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "A&#46; P&#233;rez-Plaza"
                            1 => "M&#46;J&#46; Concha-Garz&#243;n"
                            2 => "G&#46; Solano-L&#243;pez"
                            3 => "D&#46; De Argila"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Immunology"
                        "fecha" => "2014"
                        "volumen" => "33"
                        "paginaInicial" => "147"
                        "paginaFinal" => "148"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment with omalizumab in a 16- year-old Caucasian girl with refractory solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Arasi"
                            1 => "G&#46; Crisafulli"
                            2 => "L&#46; Caminiti"
                            3 => "F&#46; Guarneri"
                            4 => "T&#46; Aversa"
                            5 => "F&#46; Porcaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12413"
                      "Revista" => array:7 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015"
                        "volumen" => "26"
                        "paginaInicial" => "583"
                        "paginaFinal" => "585"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26033828"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0870255115000086"
                          "estado" => "S300"
                          "issn" => "08702551"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful omalizumab treatment of severe solar urticaria in a 6-year-old child"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "A&#46; Levi"
                            1 => "Y&#46; Tal"
                            2 => "Z&#46; Dranitzki"
                            3 => "M&#46; Shalit"
                            4 => "D&#46;E&#46; Claes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/pai.12441"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pediatr Allergy Immunol"
                        "fecha" => "2015"
                        "volumen" => "26"
                        "paginaInicial" => "588"
                        "paginaFinal" => "590"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26172942"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Successful treatment of solar urticaria with anti-immunoglobulin E therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "O&#46; G&#252;zelbey"
                            1 => "E&#46; Ardelean"
                            2 => "M&#46; Magerl"
                            3 => "T&#46; Zuberbier"
                            4 => "M&#46; Maurer"
                            5 => "M&#46; Metz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1398-9995.2008.01879.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Allergy"
                        "fecha" => "2008"
                        "volumen" => "63"
                        "paginaInicial" => "1563"
                        "paginaFinal" => "1565"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18925897"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Partial improvement of solar urticaria after omalizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "K&#46;H&#46; Waibel"
                            1 => "D&#46;A&#46; Reese"
                            2 => "R&#46;G&#46; Hamilton"
                            3 => "R&#46; Devillez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaci.2009.11.007"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Allergy Clin Immunol"
                        "fecha" => "2010"
                        "volumen" => "125"
                        "paginaInicial" => "490"
                        "paginaFinal" => "491"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20159260"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness of omalizumab in severe solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; De Dios-Vel&#225;zquez"
                            1 => "M&#46; G&#243;nzalez-De Arriba"
                            2 => "V&#46; Beteta-Gorriti"
                            3 => "E&#46; Mac&#237;as"
                            4 => "V&#46; Campan&#243;n-Toro"
                            5 => "I&#46; D&#225;vila"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.anai.2015.11.019"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Allergy Asthma Immunol"
                        "fecha" => "2016"
                        "volumen" => "116"
                        "paginaInicial" => "256"
                        "paginaFinal" => "264"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26774975"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Three cases of solar urticaria successfully treated with omalizumab"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46; Baliu-Piqu&#233;"
                            1 => "P&#46; Aguilera-Peir&#243;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.13001"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2015"
                        "volumen" => "30"
                        "paginaInicial" => "704"
                        "paginaFinal" => "706"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25640906"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria&#58; A retrospective clinical analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46; Metz"
                            1 => "T&#46; Ohanyan"
                            2 => "M&#46;K&#46; Church"
                            3 => "M&#46; Maurer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jdermsci.2013.08.011"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Dermatol Sci"
                        "fecha" => "2014"
                        "volumen" => "73"
                        "paginaInicial" => "57"
                        "paginaFinal" => "62"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24060603"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0735109713062335"
                          "estado" => "S300"
                          "issn" => "07351097"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Unique co-existence of cold and solar urticaria and its efficient treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46; Zimmer"
                            1 => "A&#46; Pevelling-Oberhag"
                            2 => "A&#46; Weber"
                            3 => "T&#46;T&#46; Gilfert"
                            4 => "U&#46; Rady-Pizarro"
                            5 => "P&#46; Staubach"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.14354"
                      "Revista" => array:7 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2016"
                        "volumen" => "174"
                        "paginaInicial" => "1150"
                        "paginaFinal" => "1152"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26678859"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673609605663"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Failure of omalizumab &#40;Xolair&#41; in the treatment of a case of solar urticaria caused by ultraviolet A and visible light"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "G&#46; Duchini"
                            1 => "W&#46; B&#228;umler"
                            2 => "A&#46;J&#46; Bircher"
                            3 => "K&#46; Scherer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1600-0781.2011.00624.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Photodermatol Photoimmunol Photomed"
                        "fecha" => "2011"
                        "volumen" => "27"
                        "paginaInicial" => "336"
                        "paginaFinal" => "337"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22092741"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Failure of omalizumab in the treatment of solar urticaria"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46; M&#252;ller"
                            1 => "C&#46;M&#46; Schempp"
                            2 => "T&#46; Jakob"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.12922"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2016"
                        "volumen" => "30"
                        "paginaInicial" => "524"
                        "paginaFinal" => "525"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25546321"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Omalizumab in patients with severe and refractory solar urticaria&#58; A phase II multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Aubin"
                            1 => "M&#46; Avenel-Audran"
                            2 => "M&#46; Jeanmougin"
                            3 => "H&#46; Adamski"
                            4 => "J&#46;L&#46; Peyron"
                            5 => "M&#46;C&#46; Marguery"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2015.11.021"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2016"
                        "volumen" => "74"
                        "paginaInicial" => "574"
                        "paginaFinal" => "575"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26892659"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010800000008/v1_201710010015/S1578219017302408/v1_201710010015/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "34944"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "e- Case Report"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000008/v1_201710010015/S1578219017302408/v1_201710010015/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017302408?idApp=UINPBA000044"
]
Article information
ISSN: 15782190
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 11 6 17
2024 October 86 49 135
2024 September 85 27 112
2024 August 116 50 166
2024 July 101 29 130
2024 June 118 37 155
2024 May 65 31 96
2024 April 82 31 113
2024 March 77 25 102
2024 February 47 26 73
2024 January 55 41 96
2023 December 49 22 71
2023 November 77 29 106
2023 October 61 26 87
2023 September 75 30 105
2023 August 28 21 49
2023 July 67 39 106
2023 June 39 21 60
2023 May 51 25 76
2023 April 64 14 78
2023 March 47 17 64
2023 February 56 21 77
2023 January 44 24 68
2022 December 61 44 105
2022 November 31 25 56
2022 October 19 14 33
2022 September 27 45 72
2022 August 33 38 71
2022 July 25 45 70
2022 June 27 20 47
2022 May 42 42 84
2022 April 63 35 98
2022 March 61 63 124
2022 February 37 51 88
2022 January 50 34 84
2021 December 33 36 69
2021 November 37 51 88
2021 October 54 59 113
2021 September 31 38 69
2021 August 57 52 109
2021 July 41 32 73
2021 June 54 30 84
2021 May 49 45 94
2021 April 95 56 151
2021 March 75 33 108
2021 February 69 30 99
2021 January 48 27 75
2020 December 64 25 89
2020 November 34 17 51
2020 October 51 11 62
2020 September 50 20 70
2020 August 39 28 67
2020 July 38 18 56
2020 June 49 35 84
2020 May 25 21 46
2020 April 31 14 45
2020 March 32 13 45
2020 February 7 0 7
2020 January 4 0 4
2019 December 8 0 8
2019 November 2 0 2
2019 September 8 0 8
2019 August 6 0 6
2019 July 4 0 4
2019 June 7 0 7
2019 May 3 1 4
2019 April 4 0 4
2019 March 4 0 4
2019 February 2 0 2
2019 January 5 0 5
2018 December 3 0 3
2018 November 2 0 2
2018 October 3 0 3
2018 September 3 0 3
2018 August 1 0 1
2018 February 24 5 29
2018 January 38 7 45
2017 December 50 14 64
2017 November 46 11 57
2017 October 131 54 185
2017 September 1 17 18
2017 August 3 11 14
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?